Evoke Pharma (NASDAQ:EVOK) Shares to Reverse Split on Thursday, August 1st

Evoke Pharma, Inc. (NASDAQ:EVOK)’s stock is going to reverse split on Thursday, August 1st. The 1-12 reverse split was announced on Thursday, August 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, August 1st.

Evoke Pharma Stock Down 16.4 %

Shares of EVOK stock traded down $0.08 on Tuesday, reaching $0.42. 112,058 shares of the stock were exchanged, compared to its average volume of 42,557. The firm has a 50 day moving average of $0.52 and a two-hundred day moving average of $0.57. Evoke Pharma has a 1-year low of $0.36 and a 1-year high of $1.67. The stock has a market cap of $3.59 million, a P/E ratio of -0.23 and a beta of 0.38.

Evoke Pharma (NASDAQ:EVOK) last announced its quarterly earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($0.17) earnings per share for the quarter. Evoke Pharma had a negative return on equity of 4,908.09% and a negative net margin of 116.75%. The business had revenue of $1.74 million for the quarter.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Evoke Pharma in a research report on Tuesday, July 23rd. They set a “sell” rating for the company.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.